Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Kane Biotech Inc. V.KNE

Alternate Symbol(s):  KNBIF

Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. It has a portfolio of biotechnologies and products, which includes StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, coactiv+, DermaKB and DermaKB Biofilm. Its Wound Care & Surgical division is focused on the product development of DispersinB for applications in chronic wound care. Its bluestem product line includes water additives, chews, spray and dental wipes. Its other products in development stage include Coactiv+, antimicrobial wound rinse for use in acute and chronic wounds; Coactiv+, antimicrobial surgical hydrogel for use in surgical and acute wounds, and DispersinB Gel for prosthetic joint infection. It also provides Scalp Detoxifier, Shampoo and Shampoo Bars. Its primary markets for its technologies are animal health and human health.


TSXV:KNE - Post by User

Comment by StoneMan45on Apr 23, 2021 8:06am
98 Views
Post# 33053824

RE:Hi all. What are realistic price targets here for the...

RE:Hi all. What are realistic price targets here for the...short term likely a fairly sizeable jump up ...next 2 months most likely and I think at <u>minimum</u> we will see over .45 as the valuation placed on the initial jv to be formed is 70 mil and Kane will own 90% of that . The .45 min is only cause this is the determined valuation and who knows what the market will place on it. The truth is that this wound care deal is much much larger than that as it does actually include MTEC as small partner being that is part of how the MTEC (US Army) 2.7 million US grant works. The wound care gel alone will eventually take the company over 500 mil in market value (about 2-3 years time) then throw in Stem which becomes active in selling faiirly soon (15 mil evaluation with Kane holding 66.7 %) , 2 milestone payments from Dechra and Animal Care that together are $1.2 million US
The Company also aims to achieve a key milestone by obtaining the internationally recognized efficacy certification, which would result in $500,000 USD and $700,000 CAD in milestone payments pursuant to the Dechra and Animalcare Agreements. As announced March 10, 2021 preliminary analysis of data from efficacy trials for STEM’s pet oral care water additive have met the primary endpoint.
. Also the DermaKB line that has started with sever danduff, scalp issues but will be including ear etc.. The DermaKB is 100% theirs for now and this market could be huge. Take the over 4200 trial participants (Canada and US) of which over 50% said they would use both the detoxifier and shampoo together. This would be a very high customer acquisition and make the model of customer referral growth extremely compelling. Start with 2000 customers and they manage to refer just 1 new customer each month (the new customer is now referring 1 new customer a month on-and-on) . The growth would be over a million in 1 year and second year it breaks out. 
Preliminary findings are compelling with 83% of participants in the Detoxifier + Shampoo leg of the trial, when asked which product they would use again, identified the Detoxifier and Shampoo in combination (52%)

Lot going on for Kane and the near and far future looks very good. 2 years from now I see Kane over 500 mil market cap could be much higher. Next 2 months at least 45 mil market cap . 1 year , likely over 80 mil market cap

<< Previous
Bullboard Posts
Next >>